Become A Wiser, More Profitable Investor

✅   Immuno-oncology recapitulates ontogeny: Modern cell and gene therapy for cancer

science

Immuno-oncology (IO) has had over a century to develop from the original seminal insights of Virchow in 1863, seeing inflammation and lymphoid infiltrates as a common anlage for many adult tumors. That IO has become a central pillar of cancer treatment has come about because of the remarkable clinical and subsequent commercial success of immune checkpoint blockade (ICB) in the last fifteen years. This as well includes now approved cell and gene therapies for patients with cancer including an...

NCBI     Mar 29, 2025